Ohba, S.; Murayama, K.; Teranishi, T.; Kumon, M.; Nakae, S.; Yui, M.; Yamamoto, K.; Yamada, S.; Abe, M.; Hasegawa, M.;
et al. Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma. Cancers 2023, 15, 952.
https://doi.org/10.3390/cancers15030952
AMA Style
Ohba S, Murayama K, Teranishi T, Kumon M, Nakae S, Yui M, Yamamoto K, Yamada S, Abe M, Hasegawa M,
et al. Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma. Cancers. 2023; 15(3):952.
https://doi.org/10.3390/cancers15030952
Chicago/Turabian Style
Ohba, Shigeo, Kazuhiro Murayama, Takao Teranishi, Masanobu Kumon, Shunsuke Nakae, Masao Yui, Kaori Yamamoto, Seiji Yamada, Masato Abe, Mitsuhiro Hasegawa,
and et al. 2023. "Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma" Cancers 15, no. 3: 952.
https://doi.org/10.3390/cancers15030952
APA Style
Ohba, S., Murayama, K., Teranishi, T., Kumon, M., Nakae, S., Yui, M., Yamamoto, K., Yamada, S., Abe, M., Hasegawa, M., & Hirose, Y.
(2023). Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma. Cancers, 15(3), 952.
https://doi.org/10.3390/cancers15030952
